27.68
+0.43(+1.58%)
Currency In CNY
Address
No. 36, Jinghai Er Road
Beijing, 100176
China
Phone
86 10 6751 9888
Website
Sector
Healthcare
Industry
Biotechnology
Employees
555
First IPO Date
April 15, 2011
| Name | Title | Pay | Year Born |
| Maorong Yu | Secretary of the Board & Deputy GM | 0 | 1981 |
| Shicheng Li | Head of Accounting & Financial Director | 0 | 1982 |
| Wang Chao | General Manager | 0 | 1982 |
Staidson (Beijing) BioPharmaceuticals Co., Ltd. primarily engages in the research and development, production, and marketing of therapeutic drugs in China. The company offers protein drugs, including therapeutic monoclonal antibody drugs; gene therapy/cell therapy drugs; and chemical drugs. It principally offers its products under the fields of nervous system related, infectious, gastrointestinal, urinary system, and autoimmune diseases. The company has a strategic collaboration with Pivotal S.L. to assess BDB-001, a monoclonal anti-C5a antibody, in a clinical trial in Europe in progressive severe COVID-19 patients caused by SARS-CoV-2. Staidson (Beijing) BioPharmaceuticals Co., Ltd. was founded in 2002 and is based in Beijing, China.
